Neoplasms: all 9,616 studies
Page 70 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.
- LOAd703 Oncolytic Virus Therapy for Pancreatic CancerCompletedNCT02705196Phase 1/2
- Cyclosporine Plus Methotrexate or AlemtuzumabTerminatedNCT02701517Phase 2
- Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by SurgeryCompletedNCT02700230Phase 1
- Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric CancerStatus unknownNCT02697838Phase 2
- Radiation Impact on Thromboembolic EventsCompletedNCT02696447
- CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation TherapyCompletedNCT02693080Phase 1
- Biomarker Analysis of Central Nervous System TumorsTerminatedNCT02692898
- Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid TumorsCompletedNCT02691793Phase 4
- Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid TumorsWithdrawnNCT02691780Not applicable
- Study to Evaluate the Safety and Efficacy of Pazopanib, in Subject With Refractory Solid TumorsCompletedNCT02691767Not applicable
- Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHLActive, not recruitingNCT02690545Phase 1/2
- Study of DS-1123a in Advanced Solid TumoursCompletedNCT02690337Phase 1
- Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid TumorsWithdrawnNCT02689336Phase 2
- Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid TumorsCompletedNCT02688881Phase 4
- A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFRTerminatedNCT02687386Phase 1
- Evaluation of Satisfaction With Quality of Care on the Palliative Care UnitCompletedNCT02686411
- Prospective Study of Patients With Rheumatoid Arthritis After the Age of 65TerminatedNCT02686320
- A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast CancerWithdrawnNCT02685306Phase 2
- A Study of SHR6390 in Advanced Solid Tumor PatientsCompletedNCT02684266Phase 1
- Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain TumorsTerminatedNCT02684071Phase 2
- MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver CancerCompletedNCT02683200Early Phase 1
- Lifestyle Intervention for Prevention of Gastric NeoplasmStatus unknownNCT02679495Not applicable
- To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.TerminatedNCT02679131Phase 1
- Phase I Study of PDR001 in Patients With Advanced Malignancies.CompletedNCT02678260Phase 1
- STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian CancerCompletedNCT02676726Not applicable
- CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)Status unknownNCT02675946Phase 1
- Reliability of the Preoperative Work-up in Patients Submitted to Surgery for Cystic Neoplasms of the PancreasStatus unknownNCT02675738
- Phase 1 Study of DS-6051b in Japanese Subjects With Advanced Solid Malignant TumorsCompletedNCT02675491Phase 1
- Preoperative High Intensity Interval Training: The PHIIT TrialCompletedNCT02674815Not applicable
- A Study to Investigate the Absorption, Metabolism and Excretion of [14C]ASP8273 in Subjects With Solid TumorsWithdrawnNCT02674555Phase 1
- A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell TumorTerminatedNCT02673736Phase 1
- MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)TerminatedNCT02673021Not applicable
- Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive MalignanciesTerminatedNCT02672917Phase 1
- KTP vs CO2 Laser for the Treatment of Laryngeal CarcinomaStatus unknownNCT02672904Not applicable
- Adjuvant Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Gastric CancerCompletedNCT02672865Phase 1
- Determinants of Quality Of Life in AGEd Cancer PatientsStatus unknownNCT02672657
- A Study of Safety, Pharmacokinetics, Pharmacodynamics of JNJ-61610588 in Participants With Advanced CancerTerminatedNCT02671955Phase 1
- Enhanced Recovery After Minimally Invasive PancreaticoduodenectomyCompletedNCT02671357
- Intravenous Pentamidine for Pneumocystis Jirovecii PneumoniaCompletedNCT02669706
- Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study ProtocolStatus unknownNCT02669459Phase 3
- A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid TumorsCompletedNCT02667873Phase 1
- Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic CancerStatus unknownNCT02666612Not applicable
- Per-operating Use of a Probe for Detection of β+TerminatedNCT02666599Not applicable
- Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of Selicrelumab (RO7009789) With Vanucizumab or Bevacizumab in Participants With Metastatic Solid TumorsCompletedNCT02665416Phase 1
- T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive SystemStatus unknownNCT02662348Phase 1
- Are the Fried Criteria Predictive of a Functional Decline in Older People With Solid Malignant Tumors?CompletedNCT02662179
- Impact of Anesthesia Maintenance Methods on Long-term SurvivalCompletedNCT02660411Not applicable
- Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsCompletedNCT02658214Phase 1
- BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified TumorsWithdrawnNCT02656849Phase 2
- Transcutaneous Electrical Nerve Stimulation (TENS) for Advanced Cancer Pain PatientsCompletedNCT02655289Not applicable
- Augmented Pulse Pressure Variation to Predict Fluid Responsiveness in Open LaparotomyCompletedNCT02653469
- A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid TumorsTerminatedNCT02653196Early Phase 1
- A Study of the Safety, Pharmacokinetics, and Therapeutic Activity of RO6958688 in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen (CEA)-Positive Solid TumorsCompletedNCT02650713Phase 1
- Efficacy of a Smart Management Strategy for Health (SMASH) Program for Overcoming Cancer Crisis and Growing PositivelyCompletedNCT02650661Not applicable
- Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their ChildrenCompletedNCT02650583Not applicable
- Using an Electronic Nose to Predict Gastrointestinal Consequences of Pelvic RadiotherapyStatus unknownNCT02649491
- Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid TumorsTerminatedNCT02648711Phase 1
- Spinal Versus Epidural Analgesia in Laparotomic Liver SurgeryStatus unknownNCT02647047Not applicable
- Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid TumorsCompletedNCT02646748Phase 1
- Ovarian Tissue Cryopreservation in ChildrenActive, not recruitingNCT02646384Not applicable
- Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsCompletedNCT02646319Early Phase 1
- Establishment of Patient Derived Cancer Cell Models to Interrogate Novel Molecular Targets in Metastatic CancerStatus unknownNCT02646228
- Thyrotropin Over-suppression and HeartCompletedNCT02645786
- Implementing an Evidence-based Computerized Decision Support System Linked to Electronic Health Records to Improve Care for Cancer PatientsCompletedNCT02645357Not applicable
- Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal CancerStatus unknownNCT02644863Phase 2
- Immunotherapy Using Autologous T Cell-Engineered With CD19-specific Chimeric Antigen Receptor for the Treatment of Recurrent /Refractory B Cell LeukemiaStatus unknownNCT02644655Phase 1/2
- Abemaciclib in Children With DIPG or Recurrent/Refractory Solid TumorsCompletedNCT02644460Phase 1
- Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain TumorsCompletedNCT02644291Phase 1
- A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced CancerCompletedNCT02640365Phase 1
- Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal MalignanciesTerminatedNCT02638909Phase 2
- A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in ChildrenActive, not recruitingNCT02637687Phase 1/2
- Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility DeterminationCompletedNCT02636855
- Vela China Study: in Cutting And Hemostasis For Gastrointestinal Epithelial Neoplasia In Chinese PopulationTerminatedNCT02636738Not applicable
- Impact of Duration Of Absolute Voice Rest on Voice Outcome After PhonomicrosurgeryTerminatedNCT02634957Not applicable
- A Study of LY2880070 in Participants With Advanced or Metastatic CancerCompletedNCT02632448Phase 1/2
- 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant TumorCompletedNCT02632370
- Immunotherapy Using Precision T Cells Specific to Personalized Neo-antigen for the Treatment of Advanced Malignant Tumor of Biliary TractStatus unknownNCT02632019Phase 1/2
- Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)CompletedNCT02631863Phase 2
- Intraoperative Imaging of Pituitary Adenomas by OTLTerminatedNCT02629549Phase 1
- The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP)Status unknownNCT02629510Phase 4
- Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast CancerWithdrawnNCT02627430Phase 1
- ICanSTEP : Increasing Physical Activity With Text MessagingCompletedNCT02627079Not applicable
- Study of Daratumumab in Combination With Dexamethasone in Resistant or Refractory Multiple MyelomaCompletedNCT02626481Phase 2
- A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid TumorsCompletedNCT02626234Phase 1
- Phase Ib Study of Alpelisib With Cisplatin in Patients With HPV+ Solid Tumor MalignanciesTerminatedNCT02620839Phase 1
- Concordance Between ctDNA Assay and FoundationOneCompletedNCT02620527
- Efficacy and Safety of TCA vs. ECA for the Treatment of AIN in HIV-positive PatientsCompletedNCT02615860Not applicable
- Combination of Interferon-gamma and Nivolumab for Advanced Solid TumorsCompletedNCT02614456Phase 1
- Proof -of -Concept Study To Stratify Targeted Therapies Adapted To Molecular ProfilingCompletedNCT02613962Not applicable
- Effect of Smartphone App on ActivityStatus unknownNCT02612402Not applicable
- Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic DiseaseCompletedNCT02612350
- Effects of Resistance and Endurance Training in Pediatric Cancer Patients During Intensive Treatment PhaseCompletedNCT02612025Not applicable
- Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer SurvivorsCompletedNCT02611544Not applicable
- Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsCompletedNCT02611024Phase 1/2
- Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid TumorsCompletedNCT02610361Phase 1
- Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours.CompletedNCT02610075Phase 1
- Single Versus Multiple Fractionated SSRS for Spinal MetastasesStatus unknownNCT02608866Not applicable
- Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid TumorsActive, not recruitingNCT02608385Phase 1
- Medical Treatment Decision Making Using Adaptive Conjoint AnalysisTerminatedNCT02608307
- Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic NeoplasmsStatus unknownNCT02606539Phase 2/3